Jim Cramer knows that many of the FANG faithful are tempted to sell. He makes the case as to why Facebook, Amazon, Netflix & Google could still surge.» Read More
Japanese Prime Minister Abe's historic address to Congress will likely bolster the Trans-Pacific Partnership and add support to the Nikkei.
A closer look at the mega-cap leaders of the S&P 500 over the last 30 years suggests that Apple’s market value could balloon to more than $1 trillion.
Should you stay away from U.S. stocks? Dennis Gartman thinks he's found a better place to buy.
Coach shares fell following third-quarter results that showed its comparable-store sales and earnings decelerated.
Sterling has boomed since mid-April and some analysts say the rally could run way beyond next month’s national election.
Even as stocks dipped a bit in March, margin debt rose to an all-time high. But here's why traders aren't worrying.
Some of the names on the move ahead of the open.
The Fed begins a two-day meeting Tuesday, setting up a winning short term trade in certain slices of the stock market, if history is any guide.
"Fast Money" traders discussed how to play Apple and stocks that trade with the tech behemoth after its quarterly earnings beat.
The "Fast Money" traders give their final trades of the day.
There's a big bullish force for this stock market about to resume in just one week, according to Goldman Sachs. Here's how to profit from it.
Bankrate.com looks at how various investments performed over the last 10 years.
Jim Cramer sat down with Theranos CEO on how a college dropout developed a product that could change the face of medicine forever
Financials are primed to break out from a sluggish run partly fueled by low interest rates, former Barclays CEO Bob Diamond said.
Jim Cramer spoke with the CEO of Intel to find out if the technology can keep up with a changing tech landscape.
Oil is up over 30 percent since its low in March. One pro predicts the rally will continue, but another says prices will fall near term.
It might soon be time to hand your money to the robots.
Biotech is getting roughed up, after leading the market's gains this year.
Check out the companies making headlines after the bell Monday: Apple, Container Store, Barracuda & more.
Biotech, which has been a market leader all year, is weak, with both the market-cap weighted IBB and equal weighted XBI down roughly 4 percent each.